Search PubMed⌕ Search

Biomedical subjects

G A Mitchell

Publications and source records attributed to G A Mitchell.

104 records · Page 6Linked to original sources

Antibody production in milk serum after virus instillation of goat mammary gland. IV. Experiments with protective properties of specific influenza antibody associated with lactogammaglobulin.

The protective property of specific antibody against influenza PR8 associated with lactogammaglobulin was investigated. The antibody was given to groups of mice by the intramuscular and respiratory routes before exposure to adapted virus contained in aerosols of two concentrations, one being capable of killing all unprotected mice. A temporary, but well-marked, passive immunity was demonstrated in those receiving antibody intramuscularly; if a second injection was given later, resistance was prolonged. A second respiratory challenge of concentrated adapted virus given to survivors three weeks later revealed evidence of immunity. Antibody given by the respiratory route gave varying results. When given once, either a fleeting protection or protection which led to an active immunity followed. This appeared to depend on whether a degree of propagation within the lung took place for several days after challenge. When antibody was given daily and propagation failed to take place, only a temporary immunity resulted and the mice were unprotected against another challenge.

Aerosols↗

Evolution and man.

Explore the source record for details and available documents.

Anthropology↗

Tyrosinemia: a review.

Hypertyrosinemia encompasses several entities, of which tyrosinemia type I (or hepatorenal tyrosinemia, HT1) results in the most extensive clinical and pathological manifestations involving mainly the liver, kidney, and peripheral nerves. The clinical findings range from a severe hepatopathy of early infancy to chronic liver disease and rickets in the older child; gradual refinements in the diagnosis and medical management of this disorder have greatly altered its natural course, mirroring recent advances in the field of metabolic diseases in the past quarter century. Hepatorenal tyrosinemia is the inborn error with the highest incidence of progression to hepatocellular carcinoma, likely due to profound mutagenic effects and influences on the cell cycle by accumulated metabolites. The appropriate follow-up of patients with cirrhosis, the proper timing of liver transplantation in the prevention of carcinoma, and the long-term evolution of chronic renal disease remain important unresolved issues. The introduction of a new pharmacologic agent, NTBC, holds the hope of significantly alleviating some of the burdens of this disease. Mouse models of this disease have permitted the exploration of newer treatment modalities, such as gene therapy by viral vectors, including ex vivo and in utero methods. Finally, recent observations on spontaneous genetic reversion of the mutation in HT1 livers challenge conventional concepts in human genetics.

Animals↗